Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.
about
The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemiaTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseThe impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysisOmega-3 supplements and cardiovascular diseasesH2S-releasing nanoemulsions: a new formulation to inhibit tumor cells proliferation and improve tissue repair.Low-n-6 and low-n-6 plus high-n-3 diets for use in clinical research.Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review.The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysisEffects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusionThe Mediterranean diet, its components, and cardiovascular disease.Baseline plasma fatty acids profile and incident cardiovascular events in the SU.FOL.OM3 trial: the evidence revisited.The effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends…Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proarrhythmic effect.Why Do We Still Need Large Scale Clinical Trial: The Case of n-3 PUFA.The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease.{Omega}-3 fatty acid supplement use in the 45 and Up Study CohortD-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injuryDocosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adultsThe differential effects of EPA and DHA on cardiovascular risk factors.Treatment of lipid disorders in obesity.Dyslipidemia: management using optimal lipid-lowering therapy.Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.Long-chain omega-3 fatty acids: time to establish a dietary reference intake.Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications.Mediterranean Diet and Cardiovascular Risk: Beyond Traditional Risk Factors.Gamma-linolenic acid, Dihommo-gamma linolenic, Eicosanoids and Inflammatory Processes.Modulation of the vascular endothelium functioning by dietary components, the role of epigenetics.Management of Stable Angina - Current Guidelines: A Critical Appraisal.Oxidized eicosapentaenoic acids more potently reduce LXRα-induced cellular triacylglycerol via suppression of SREBP-1c, PGC-1β and GPA than its intact form.Effects of omega-3 fatty acids on the frequency, severity, and duration of migraine attacks: A systematic review and meta-analysis of randomized controlled trials.The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction.Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introductionBeneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome.Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.Scientific Opinion on the Tolerable Upper Intake Level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA)Native Oils from Apple, Blackcurrant, Raspberry, and Strawberry Seeds as a Source of Polyenoic Fatty Acids, Tocochromanols, and Phytosterols: A Health Implication
P2860
Q26738554-CD877656-7F11-4ED2-B259-4CB641B3AE92Q26745946-90DB079C-7290-4181-9ED5-8178A843EB42Q26852020-2C399015-B86F-41E2-865E-09CD5B220074Q26864908-41C1F69D-38BD-4DBB-9071-BC24D0493B89Q30358087-ACC37971-F1FB-4257-B9A1-948AE6131528Q33881432-09A53BC1-399F-47B4-9992-72BC33E26872Q34275388-FA8AED2A-46CC-42EA-ACC2-EA971A9C4CF8Q34305333-788664C2-0554-47DB-9D90-3931A8FC24E2Q34629651-65D7D1F4-FABC-4E44-98F2-12F235C63EFAQ34822757-957F01B6-DB6E-4DBD-BB0C-BA03A2D76C58Q35118108-7A9A07EF-A3B0-47F0-862F-A6C51B89E2C6Q35141968-183D67F8-ABBD-4265-A242-57D54DD3B30BQ35865078-72127C54-862B-4344-BA7E-38B7F217F156Q36049390-2774E502-6DCC-4E39-B224-8EDB09482A14Q36064570-818C1ED2-113A-49BC-BD0B-66CC9BA9904DQ36495874-0B27965C-C36C-42C9-BFDB-7E160533AA79Q36809876-FC8367D9-3164-4070-90CB-C1752843779DQ36860274-F9ECC956-BC5F-4FE6-9A2F-53C1294812A9Q37310534-33572E4F-0905-4A1B-A686-BB37692FB0C9Q37846894-1C4C908B-C45C-4C01-B95E-A92817062C61Q37923978-AAD2CFDF-4C0A-4100-8046-10DFE75AAC48Q38049066-6AE78F68-8448-4959-9890-AA73C758B0ECQ38099615-93A61842-2CB7-441C-AA31-BD457491C654Q38113494-9F890AB0-9708-4D8D-A23F-AE4683D339CAQ38151841-9C83F8A0-E02E-4B7C-B1FD-604005EA7086Q38222135-006ABC43-75DD-4713-8D96-3DBF16DB7E3DQ38239465-790E3B68-4BBD-4347-9BCF-E210B96491ACQ38809442-4D7EE0EC-61B6-4421-9515-8D02ED242744Q38880608-6175915B-FD9F-427B-93D7-B0181EF75DB8Q38957123-49B1EE84-315C-46B7-8059-31B9C12CC858Q39151146-57125C5F-A264-41EC-930B-7423059A7EEBQ39406841-C3FAC4BA-C11B-448F-95C2-F6ACA9D1EFBAQ41076426-34982A77-8FBF-49F8-94E3-5FE66455E784Q41996741-B298DC04-81D7-4C23-9163-35672A5CA278Q42232637-C2983F4C-992E-426C-B5B2-EF43D73135EEQ45064553-0BC641FE-6934-4D94-986D-B41C5ADF0A18Q47152105-38407547-2284-47EC-BEE2-7D01BB3AC461Q59112464-22CAB9EA-DC05-4A29-8249-431C2E0FE7A3
P2860
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@ast
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@en
type
label
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@ast
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@en
prefLabel
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@ast
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@en
P2093
P2860
P31
P50
P921
P356
P1476
Omega-3 fatty acids in high-ri ...... randomized controlled trials.
@en
P2093
Fouad El Khoury
Ian Schiller
Michael Bielinski
Nandini Dendukuri
P2860
P2888
P356
10.1186/1471-2261-10-24
P577
2010-06-03T00:00:00Z
P5875
P6179
1052214397